Differential Expression Analysis
YS-like / specifying-HSC Comparison
Note: The Fold Change value for up-regulated genes is displayed in red; down-regulated values are displayed in blue.
| Gene | Annotation | pval | Fold Change (log2ratio) |
|---|---|---|---|
| hapln1 | hyaluronan and proteoglycan link protein 1 | 1.820e-11 | 5.028e+0 |
| hbb-bh1 | hemoglobin Z, beta-like embryonic chain | 4.526e-5 | 4.388e+0 |
| loc100044263 | hypothetical protein LOC100044263 | 3.832e-5 | 4.354e+0 |
| prtg | protogenin homolog (Gallus gallus) | 7.500e-17 | 3.676e+0 |
| gm784 | gene model 784, (NCBI) | 6.218e-13 | 3.674e+0 |
| tspan12 | tetraspanin 12 | 9.773e-9 | 3.546e+0 |
| gucy1a3 | guanylate cyclase 1, soluble, alpha 3 | 7.513e-11 | 3.393e+0 |
| slc38a4 | solute carrier family 38, member 4 | 2.657e-6 | 3.237e+0 |
| sall4 | sal-like 4 (Drosophila) | 4.260e-10 | 3.189e+0 |
| cap2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 2.412e-6 | 3.162e+0 |
| gsta4 | glutathione S-transferase, alpha 4 | 4.832e-5 | 3.141e+0 |
| etv2 | ets variant gene 2 | 1.285e-7 | 3.115e+0 |
| rnd2 | Rho family GTPase 2 | 2.707e-5 | 3.056e+0 |
| heph | hephaestin | 3.285e-7 | 2.990e+0 |
| snhg3 | small nucleolar RNA host gene (non-protein coding) 3 | 1.573e-8 | 2.930e+0 |
| zfp711 | zinc finger protein 711 | 4.750e-5 | 2.891e+0 |
| gfi1b | growth factor independent 1B | 2.371e-12 | 2.878e+0 |
| tmem163 | transmembrane protein 163 | 3.641e-13 | 2.848e+0 |
| bc023969 | cDNA sequence BC023969 | 2.442e-7 | 2.795e+0 |
| cth | cystathionase (cystathionine gamma-lyase) | 1.386e-6 | 2.744e+0 |
| hba-x | hemoglobin X, alpha-like embryonic chain in Hba complex | 9.631e-3 | 2.695e+0 |
| mest | mesoderm specific transcript | 1.305e-5 | 2.694e+0 |
| sox18 | SRY-box containing gene 18 | 8.927e-7 | 2.661e+0 |
| tmem47 | transmembrane protein 47 | 2.092e-6 | 2.640e+0 |
| fgf13 | fibroblast growth factor 13 | 1.788e-14 | 2.614e+0 |
| nckap1 | NCK-associated protein 1 | 7.208e-6 | 2.602e+0 |
| 2610019f03rik | RIKEN cDNA 2610019F03 gene | 9.816e-6 | 2.552e+0 |
| kdr | kinase insert domain protein receptor | 2.133e-7 | 2.525e+0 |
| wasf1 | WASP family 1 | 1.985e-12 | 2.507e+0 |
| d030007l05rik | RIKEN cDNA D030007L05 gene | 2.352e-6 | 2.463e+0 |
| podxl | podocalyxin-like | 5.974e-7 | 2.463e+0 |
| eda2r | ectodysplasin A2 isoform receptor | 2.521e-4 | 2.460e+0 |
| gad2 | glutamic acid decarboxylase 2 | 2.083e-5 | 2.456e+0 |
| clec1b | C-type lectin domain family 1, member b | 3.516e-4 | 2.456e+0 |
| gstm2 | glutathione S-transferase, mu 2 | 1.063e-3 | 2.449e+0 |
| lin28 | lin-28 homolog (C. elegans) | 2.901e-7 | 2.412e+0 |
| f2r | coagulation factor II (thrombin) receptor | 6.058e-4 | 2.384e+0 |
| prkar2b | protein kinase, cAMP dependent regulatory, type II beta | 4.429e-5 | 2.355e+0 |
| 8030474k03rik | RIKEN cDNA 8030474K03 gene | 2.971e-5 | 2.351e+0 |
| unc5c | unc-5 homolog C (C. elegans) | 2.211e-3 | 2.343e+0 |
| wdr40b | WD repeat domain 40B | 1.713e-4 | 2.325e+0 |
| aard | alanine and arginine rich domain containing protein | 5.835e-4 | 2.319e+0 |
| a930009l07rik | RIKEN cDNA A930009L07 gene | 2.143e-4 | 2.318e+0 |
| gulp1 | GULP, engulfment adaptor PTB domain containing 1 | 1.617e-6 | 2.307e+0 |
| 9230110c19rik | RIKEN cDNA 9230110C19 gene | 5.327e-7 | 2.289e+0 |
| 2310016c16rik | RIKEN cDNA 2310016C16 gene | 6.979e-5 | 2.282e+0 |
| rhoj | ras homolog gene family, member J | 2.582e-6 | 2.278e+0 |
| bex4 | brain expressed gene 4 | 4.302e-5 | 2.263e+0 |
| bmp4 | bone morphogenetic protein 4 | 1.732e-4 | 2.258e+0 |
| tal1 | T-cell acute lymphocytic leukemia 1 | 5.781e-8 | 2.246e+0 |
| tmco2 | transmembrane and coiled-coil domains 2 | 2.086e-3 | 2.213e+0 |
| bc061212 | cDNA sequence BC061212 | 1.055e-3 | 2.212e+0 |
| gypa | glycophorin A | 9.147e-4 | 2.204e+0 |
| rps6ka6 | ribosomal protein S6 kinase polypeptide 6 | 1.321e-5 | 2.201e+0 |
| lhfp | lipoma HMGIC fusion partner | 2.200e-6 | 2.198e+0 |
| trim71 | tripartite motif-containing 71 | 5.341e-13 | 2.191e+0 |
| aplnr | apelin receptor | 4.246e-4 | 2.190e+0 |
| mum1l1 | melanoma associated antigen (mutated) 1-like 1 | 1.201e-5 | 2.183e+0 |
| syde2 | synapse defective 1, Rho GTPase, homolog 2 (C. elegans) | 7.881e-6 | 2.166e+0 |
| tek | endothelial-specific receptor tyrosine kinase | 1.926e-3 | 2.157e+0 |
| tspan6 | tetraspanin 6 | 2.184e-3 | 2.154e+0 |
| dbc1 | deleted in bladder cancer 1 (human) | 3.533e-11 | 2.124e+0 |
| eraf | erythroid associated factor | 3.686e-2 | 2.117e+0 |
| loc100045217 | similar to Transmembrane protein with EGF-like and two follistatin-like domains 1 | 9.905e-5 | 2.099e+0 |
| car2 | carbonic anhydrase 2 | 2.356e-3 | 2.089e+0 |
| tie1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 1.265e-5 | 2.079e+0 |
| 9230114k14rik | RIKEN cDNA 9230114K14 gene | 1.964e-6 | 2.075e+0 |
| gchfr | GTP cyclohydrolase I feedback regulator | 5.810e-4 | 2.055e+0 |
| homer2 | homer homolog 2 (Drosophila) | 8.998e-6 | 2.028e+0 |
| d930003e18rik | RIKEN cDNA D930003E18 gene | 9.311e-5 | 2.026e+0 |
| hoxd1 | homeo box D1 | 3.954e-3 | 2.025e+0 |
| lrp11 | low density lipoprotein receptor-related protein 11 | 1.307e-7 | 2.018e+0 |
| mettl7a1 | methyltransferase like 7A1 | 9.537e-12 | -2.002e+0 |
| bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 7.835e-8 | -2.002e+0 |
| maf | avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene homolog | 4.166e-3 | -2.003e+0 |
| ms4a2 | membrane-spanning 4-domains, subfamily A, member 2 | 6.935e-4 | -2.012e+0 |
| cd24a | CD24a antigen | 1.166e-3 | -2.012e+0 |
| pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 | 1.220e-4 | -2.017e+0 |
| s100a11 | S100 calcium binding protein A11 (calgizzarin) | 7.341e-7 | -2.017e+0 |
| pld1 | phospholipase D1 | 2.761e-5 | -2.017e+0 |
| ptpn22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 2.807e-5 | -2.018e+0 |
| ifitm1 | interferon induced transmembrane protein 1 | 5.415e-3 | -2.022e+0 |
| tmem141 | transmembrane protein 141 | 3.312e-4 | -2.023e+0 |
| hlf | hepatic leukemia factor | 1.145e-5 | -2.028e+0 |
| il10rb | interleukin 10 receptor, beta | 2.227e-9 | -2.031e+0 |
| tnfrsf13b | tumor necrosis factor receptor superfamily, member 13b | 3.079e-6 | -2.031e+0 |
| lonrf3 | LON peptidase N-terminal domain and ring finger 3 | 2.018e-6 | -2.033e+0 |
| pmp22 | peripheral myelin protein 22 | 9.005e-4 | -2.039e+0 |
| metrnl | meteorin, glial cell differentiation regulator-like | 4.769e-9 | -2.039e+0 |
| nfkbie | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 7.182e-6 | -2.043e+0 |
| shisa5 | shisa homolog 5 (Xenopus laevis) | 4.739e-13 | -2.045e+0 |
| gngt2 | guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 | 1.622e-4 | -2.046e+0 |
| plac8 | placenta-specific 8 | 5.719e-5 | -2.047e+0 |
| sgpl1 | sphingosine phosphate lyase 1 | 5.017e-5 | -2.051e+0 |
| irf5 | interferon regulatory factor 5 | 5.359e-8 | -2.053e+0 |
| paqr4 | progestin and adipoQ receptor family member IV | 1.822e-4 | -2.054e+0 |
| vcam1 | vascular cell adhesion molecule 1 | 1.056e-3 | -2.055e+0 |
| hist1h2bc | histone cluster 1, H2bc | 1.976e-10 | -2.055e+0 |
| nab2 | Ngfi-A binding protein 2 | 6.413e-9 | -2.056e+0 |
| srgn | serglycin | 2.242e-5 | -2.056e+0 |
| lgals1 | lectin, galactose binding, soluble 1 | 3.333e-8 | -2.059e+0 |
| rbm47 | RNA binding motif protein 47 | 7.335e-6 | -2.059e+0 |
| fndc3b | fibronectin type III domain containing 3B | 1.461e-5 | -2.061e+0 |
| mafb | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein B (avian) | 4.374e-5 | -2.061e+0 |
| ddx4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 5.747e-5 | -2.061e+0 |
| bcl3 | B-cell leukemia/lymphoma 3 | 3.109e-7 | -2.066e+0 |
| slpi | secretory leukocyte peptidase inhibitor | 1.140e-4 | -2.067e+0 |
| agpat9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | 6.445e-4 | -2.074e+0 |
| 1100001g20rik | RIKEN cDNA 1100001G20 gene | 9.170e-6 | -2.081e+0 |
| ifi30 | interferon gamma inducible protein 30 | 2.812e-6 | -2.083e+0 |
| rpl39l | ribosomal protein L39-like | 5.381e-5 | -2.094e+0 |
| trim30 | tripartite motif-containing 30 | 7.467e-7 | -2.097e+0 |
| il1rn | interleukin 1 receptor antagonist | 2.101e-3 | -2.097e+0 |
| rgl1 | ral guanine nucleotide dissociation stimulator,-like 1 | 1.426e-5 | -2.101e+0 |
| rnf19b | ring finger protein 19B | 7.440e-9 | -2.102e+0 |
| trpv2 | transient receptor potential cation channel, subfamily V, member 2 | 2.560e-11 | -2.104e+0 |
| il10 | interleukin 10 | 4.170e-3 | -2.109e+0 |
| ccl3 | chemokine (C-C motif) ligand 3 | 2.719e-3 | -2.113e+0 |
| tmem50b | transmembrane protein 50B | 1.890e-8 | -2.129e+0 |
| nucb2 | nucleobindin 2 | 3.043e-7 | -2.132e+0 |
| pilra | paired immunoglobin-like type 2 receptor alpha | 2.690e-4 | -2.135e+0 |
| prkcb | protein kinase C, beta | 5.062e-10 | -2.138e+0 |
| 2210403k04rik | RIKEN cDNA 2210403K04 gene | 1.130e-4 | -2.152e+0 |
| naip5 | NLR family, apoptosis inhibitory protein 5 | 6.038e-9 | -2.156e+0 |
| itm2c | integral membrane protein 2C | 1.488e-8 | -2.159e+0 |
| slc7a8 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 | 6.545e-6 | -2.160e+0 |
| rab32 | RAB32, member RAS oncogene family | 5.903e-4 | -2.161e+0 |
| nfkbid | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta | 5.291e-6 | -2.176e+0 |
| camk1d | calcium/calmodulin-dependent protein kinase ID | 3.434e-6 | -2.177e+0 |
| cd72 | CD72 antigen | 4.612e-6 | -2.181e+0 |
| rnpep | arginyl aminopeptidase (aminopeptidase B) | 3.225e-7 | -2.181e+0 |
| ethe1 | ethylmalonic encephalopathy 1 | 2.261e-7 | -2.184e+0 |
| irf8 | interferon regulatory factor 8 | 5.010e-5 | -2.187e+0 |
| plekha2 | pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 | 3.813e-12 | -2.193e+0 |
| lilrb3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 8.520e-9 | -2.196e+0 |
| 1100001h23rik | RIKEN cDNA 1100001H23 gene | 2.898e-4 | -2.198e+0 |
| lst1 | leukocyte specific transcript 1 | 8.412e-7 | -2.198e+0 |
| camp | cathelicidin antimicrobial peptide | 2.191e-3 | -2.199e+0 |
| psmb8 | proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) | 2.958e-12 | -2.199e+0 |
| tbxas1 | thromboxane A synthase 1, platelet | 5.020e-6 | -2.208e+0 |
| axl | AXL receptor tyrosine kinase | 2.689e-7 | -2.211e+0 |
| cyp4v3 | cytochrome P450, family 4, subfamily v, polypeptide 3 | 2.564e-5 | -2.214e+0 |
| adam8 | a disintegrin and metallopeptidase domain 8 | 1.004e-3 | -2.217e+0 |
| fcgr3 | Fc receptor, IgG, low affinity III | 3.028e-6 | -2.217e+0 |
| kcnk6 | potassium inwardly-rectifying channel, subfamily K, member 6 | 2.283e-4 | -2.220e+0 |
| blnk | B-cell linker | 8.394e-6 | -2.224e+0 |
| ifitm6 | interferon induced transmembrane protein 6 | 2.819e-5 | -2.226e+0 |
| galnt12 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 | 1.031e-9 | -2.232e+0 |
| csf2ra | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 1.220e-7 | -2.235e+0 |
| itfg3 | integrin alpha FG-GAP repeat containing 3 | 5.372e-7 | -2.236e+0 |
| fcgr2b | Fc receptor, IgG, low affinity IIb | 2.120e-5 | -2.242e+0 |
| cd52 | CD52 antigen | 2.940e-6 | -2.248e+0 |
| rel | reticuloendotheliosis oncogene | 6.714e-7 | -2.250e+0 |
| aph1c | anterior pharynx defective 1c homolog (C. elegans) | 5.538e-7 | -2.254e+0 |
| tmcc3 | transmembrane and coiled coil domains 3 | 3.860e-6 | -2.257e+0 |
| ada | adenosine deaminase | 2.969e-5 | -2.260e+0 |
| slc16a7 | solute carrier family 16 (monocarboxylic acid transporters), member 7 | 2.645e-6 | -2.260e+0 |
| au015263 | expressed sequence AU015263 | 1.405e-4 | -2.267e+0 |
| xlr | X-linked lymphocyte-regulated complex | 1.604e-5 | -2.274e+0 |
| bc006779 | cDNA sequence BC006779 | 3.359e-6 | -2.283e+0 |
| ccnd1 | cyclin D1 | 1.627e-12 | -2.283e+0 |
| emilin2 | elastin microfibril interfacer 2 | 6.148e-6 | -2.283e+0 |
| dse | dermatan sulfate epimerase | 9.976e-4 | -2.288e+0 |
| cd300lb | CD300 antigen like family member B | 9.692e-5 | -2.292e+0 |
| icam1 | intercellular adhesion molecule 1 | 6.131e-7 | -2.293e+0 |
| hspa1b | heat shock protein 1B | 7.962e-3 | -2.297e+0 |
| lpl | lipoprotein lipase | 3.765e-3 | -2.299e+0 |
| cd97 | CD97 antigen | 2.018e-10 | -2.302e+0 |
| pf4 | platelet factor 4 | 6.567e-4 | -2.302e+0 |
| 4930519l02rik | RIKEN cDNA 4930519L02 gene | 1.520e-4 | -2.302e+0 |
| cttnbp2nl | CTTNBP2 N-terminal like | 7.568e-5 | -2.304e+0 |
| b3galnt1 | UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 | 1.823e-3 | -2.304e+0 |
| apob48r | apolipoprotein B48 receptor | 2.072e-6 | -2.305e+0 |
| rnasel | ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) | 5.711e-10 | -2.307e+0 |
| ctsz | cathepsin Z | 1.115e-6 | -2.308e+0 |
| ifi203 | interferon activated gene 203 | 1.092e-6 | -2.310e+0 |
| rin2 | Ras and Rab interactor 2 | 1.726e-4 | -2.312e+0 |
| ctsc | cathepsin C | 1.114e-4 | -2.317e+0 |
| chi3l3 | chitinase 3-like 3 | 2.738e-2 | -2.318e+0 |
| 9030625a04rik | RIKEN cDNA 9030625A04 gene | 1.229e-5 | -2.318e+0 |
| ly6c1 | lymphocyte antigen 6 complex, locus C1 | 3.725e-3 | -2.321e+0 |
| sgk3 | serum/glucocorticoid regulated kinase 3 | 5.169e-7 | -2.325e+0 |
| ccdc109b | coiled-coil domain containing 109B | 3.599e-6 | -2.329e+0 |
| flt3 | FMS-like tyrosine kinase 3 | 1.241e-4 | -2.336e+0 |
| slfn4 | schlafen 4 | 2.464e-2 | -2.337e+0 |
| tnfsf9 | tumor necrosis factor (ligand) superfamily, member 9 | 8.009e-4 | -2.341e+0 |
| cmklr1 | chemokine-like receptor 1 | 8.437e-5 | -2.344e+0 |
| slfn8 | schlafen 8 | 4.113e-7 | -2.351e+0 |
| lincr | lung-inducible neuralized-related C3HC4 RING domain protein | 1.272e-3 | -2.352e+0 |
| 0610037m15rik | RIKEN cDNA 0610037M15 gene | 1.141e-3 | -2.357e+0 |
| slamf9 | SLAM family member 9 | 2.607e-6 | -2.358e+0 |
| h2-t23 | histocompatibility 2, T region locus 23 | 1.536e-8 | -2.360e+0 |
| ccl9 | chemokine (C-C motif) ligand 9 | 4.212e-3 | -2.364e+0 |
| hdac9 | histone deacetylase 9 | 1.581e-5 | -2.365e+0 |
| klf4 | Kruppel-like factor 4 (gut) | 2.121e-3 | -2.367e+0 |
| pdlim4 | PDZ and LIM domain 4 | 1.148e-4 | -2.368e+0 |
| crip1 | cysteine-rich protein 1 (intestinal) | 1.388e-7 | -2.370e+0 |
| eg626058 | predicted gene, EG626058 | 5.049e-7 | -2.371e+0 |
| cd69 | CD69 antigen | 3.048e-2 | -2.372e+0 |
| s100a6 | S100 calcium binding protein A6 (calcyclin) | 1.060e-4 | -2.373e+0 |
| cx3cr1 | chemokine (C-X3-C) receptor 1 | 1.585e-3 | -2.375e+0 |
| kcnab2 | potassium voltage-gated channel, shaker-related subfamily, beta member 2 | 7.864e-13 | -2.376e+0 |
| slc37a2 | solute carrier family 37 (glycerol-3-phosphate transporter), member 2 | 1.402e-5 | -2.376e+0 |
| tmem51 | transmembrane protein 51 | 6.022e-5 | -2.378e+0 |
| ifit3 | interferon-induced protein with tetratricopeptide repeats 3 | 2.988e-4 | -2.391e+0 |
| il1r2 | interleukin 1 receptor, type II | 6.255e-4 | -2.394e+0 |
| gadd45b | growth arrest and DNA-damage-inducible 45 beta | 2.188e-6 | -2.397e+0 |
| fgd2 | FYVE, RhoGEF and PH domain containing 2 | 1.535e-7 | -2.398e+0 |
| stfa2l1 | stefin A2 like 1 | 1.254e-4 | -2.398e+0 |
| gsdmd | gasdermin D | 2.252e-12 | -2.399e+0 |
| loc100042978 | hypothetical protein LOC100042978 | 6.712e-6 | -2.401e+0 |
| olfml3 | olfactomedin-like 3 | 1.376e-4 | -2.401e+0 |
| 4833416e15rik | RIKEN cDNA 4833416E15 gene | 3.090e-4 | -2.414e+0 |
| padi2 | peptidyl arginine deiminase, type II | 1.746e-5 | -2.415e+0 |
| cryba4 | crystallin, beta A4 | 2.097e-3 | -2.416e+0 |
| tnf | tumor necrosis factor | 3.062e-4 | -2.416e+0 |
| aa467197 | expressed sequence AA467197 | 7.479e-3 | -2.423e+0 |
| havcr2 | hepatitis A virus cellular receptor 2 | 1.546e-6 | -2.429e+0 |
| dusp5 | dual specificity phosphatase 5 | 6.813e-5 | -2.437e+0 |
| arl4c | ADP-ribosylation factor-like 4C | 2.500e-9 | -2.439e+0 |
| tgif1 | TGFB-induced factor homeobox 1 | 2.391e-7 | -2.441e+0 |
| sgk1 | serum/glucocorticoid regulated kinase 1 | 1.722e-7 | -2.441e+0 |
| rsad2 | radical S-adenosyl methionine domain containing 2 | 3.722e-4 | -2.445e+0 |
| rassf4 | Ras association (RalGDS/AF-6) domain family member 4 | 9.949e-6 | -2.457e+0 |
| entpd1 | ectonucleoside triphosphate diphosphohydrolase 1 | 8.756e-7 | -2.458e+0 |
| ebi3 | Epstein-Barr virus induced gene 3 | 7.884e-11 | -2.460e+0 |
| lgals9 | lectin, galactose binding, soluble 9 | 3.177e-10 | -2.465e+0 |
| pparg | peroxisome proliferator activated receptor gamma | 1.610e-6 | -2.471e+0 |
| e230029c05rik | RIKEN cDNA E230029C05 gene | 2.522e-5 | -2.473e+0 |
| c3 | complement component 3 | 3.119e-6 | -2.485e+0 |
| h2-l | histocompatibility 2, D region | 5.448e-11 | -2.486e+0 |
| pira1 | paired-Ig-like receptor A1 | 5.361e-6 | -2.490e+0 |
| folr2 | folate receptor 2 (fetal) | 3.943e-4 | -2.495e+0 |
| s100a4 | S100 calcium binding protein A4 | 3.472e-4 | -2.495e+0 |
| lgals3bp | lectin, galactoside-binding, soluble, 3 binding protein | 6.592e-7 | -2.500e+0 |
| ai451617 | expressed sequence AI451617 | 3.539e-8 | -2.501e+0 |
| d12ertd647e | DNA segment, Chr 12, ERATO Doi 647, expressed | 9.239e-12 | -2.502e+0 |
| cysltr1 | cysteinyl leukotriene receptor 1 | 4.981e-6 | -2.509e+0 |
| nuak2 | NUAK family, SNF1-like kinase, 2 | 6.866e-10 | -2.515e+0 |
| c030046g05 | hypothetical protein C030046G05 | 5.130e-7 | -2.515e+0 |
| traf1 | Tnf receptor-associated factor 1 | 2.321e-4 | -2.516e+0 |
| dusp1 | dual specificity phosphatase 1 | 1.558e-3 | -2.517e+0 |
| fcgrt | Fc receptor, IgG, alpha chain transporter | 3.659e-4 | -2.519e+0 |
| ppbp | pro-platelet basic protein | 1.539e-4 | -2.522e+0 |
| dtx4 | deltex 4 homolog (Drosophila) | 2.466e-7 | -2.535e+0 |
| 3110043o21rik | RIKEN cDNA 3110043O21 gene | 3.299e-9 | -2.541e+0 |
| tlr7 | toll-like receptor 7 | 8.192e-7 | -2.547e+0 |
| hoxa9 | homeo box A9 | 1.116e-7 | -2.555e+0 |
| gpr137b-ps | G protein-coupled receptor 137B, pseudogene | 3.322e-11 | -2.562e+0 |
| nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 2.453e-7 | -2.565e+0 |
| xlr4b | X-linked lymphocyte-regulated 4B | 4.784e-3 | -2.571e+0 |
| ier3 | immediate early response 3 | 3.101e-6 | -2.574e+0 |
| areg | amphiregulin | 9.043e-5 | -2.574e+0 |
| a130040m12rik | RIKEN cDNA A130040M12 gene | 1.824e-5 | -2.576e+0 |
| ptpro | protein tyrosine phosphatase, receptor type, O | 7.486e-8 | -2.577e+0 |
| rtp4 | receptor transporter protein 4 | 2.749e-7 | -2.585e+0 |
| ms4a6d | membrane-spanning 4-domains, subfamily A, member 6D | 1.486e-6 | -2.585e+0 |
| cxcl16 | chemokine (C-X-C motif) ligand 16 | 8.059e-7 | -2.593e+0 |
| gzmb | granzyme B | 3.484e-4 | -2.594e+0 |
| rassf5 | Ras association (RalGDS/AF-6) domain family member 5 | 1.466e-13 | -2.595e+0 |
| nkg7 | natural killer cell group 7 sequence | 7.794e-5 | -2.596e+0 |
| lrp1 | low density lipoprotein receptor-related protein 1 | 1.457e-6 | -2.599e+0 |
| cd27 | CD27 antigen | 6.350e-5 | -2.603e+0 |
| slc7a7 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 | 2.981e-4 | -2.610e+0 |
| c030044c12rik | RIKEN cDNA C030044C12 gene | 6.477e-6 | -2.613e+0 |
| tmem106a | transmembrane protein 106A | 1.167e-6 | -2.614e+0 |
| dusp22 | dual specificity phosphatase 22 | 4.098e-8 | -2.614e+0 |
| etv5 | ets variant gene 5 | 7.825e-6 | -2.620e+0 |
| bc023892 | cDNA sequence BC023892 | 5.847e-10 | -2.621e+0 |
| egr2 | early growth response 2 | 4.099e-3 | -2.638e+0 |
| ptgds2 | prostaglandin D2 synthase 2, hematopoietic | 9.451e-5 | -2.639e+0 |
| 1300014i06rik | RIKEN cDNA 1300014I06 gene | 1.073e-6 | -2.642e+0 |
| tifa | TRAF-interacting protein with forkhead-associated domain | 6.895e-5 | -2.643e+0 |
| spic | Spi-C transcription factor (Spi-1/PU.1 related) | 1.443e-3 | -2.648e+0 |
| parvg | parvin, gamma | 1.814e-8 | -2.648e+0 |
| mgl1 | macrophage galactose N-acetyl-galactosamine specific lectin 1 | 5.941e-6 | -2.660e+0 |
| 1200002n14rik | RIKEN cDNA 1200002N14 gene | 3.341e-6 | -2.666e+0 |
| lcp1 | lymphocyte cytosolic protein 1 | 3.064e-5 | -2.672e+0 |
| acp5 | acid phosphatase 5, tartrate resistant | 5.905e-6 | -2.677e+0 |
| cd84 | CD84 antigen | 5.846e-10 | -2.683e+0 |
| gpr183 | G protein-coupled receptor 183 | 3.095e-6 | -2.685e+0 |
| oas1g | 2'-5' oligoadenylate synthetase 1G | 2.483e-7 | -2.689e+0 |
| anxa1 | annexin A1 | 5.737e-8 | -2.705e+0 |
| ang | angiogenin, ribonuclease, RNase A family, 5 | 1.851e-5 | -2.706e+0 |
| itgal | integrin alpha L | 8.845e-9 | -2.719e+0 |
| ptger4 | prostaglandin E receptor 4 (subtype EP4) | 1.165e-4 | -2.723e+0 |
| ccl6 | chemokine (C-C motif) ligand 6 | 5.919e-4 | -2.724e+0 |
| h2-q7 | histocompatibility 2, Q region locus 7 | 5.330e-4 | -2.725e+0 |
| atp8b4 | ATPase, class I, type 8B, member 4 | 3.594e-8 | -2.727e+0 |
| pkib | protein kinase inhibitor beta, cAMP dependent, testis specific | 1.497e-10 | -2.734e+0 |
| lsp1 | lymphocyte specific 1 | 1.149e-7 | -2.735e+0 |
| tnfaip3 | tumor necrosis factor, alpha-induced protein 3 | 5.643e-5 | -2.735e+0 |
| loc73899 | hypothetical LOC73899 | 7.338e-8 | -2.750e+0 |
| psap | prosaposin | 4.157e-7 | -2.757e+0 |
| bc013712 | cDNA sequence BC013712 | 3.005e-6 | -2.758e+0 |
| ppm1h | protein phosphatase 1H (PP2C domain containing) | 5.084e-10 | -2.763e+0 |
| fpr2 | formyl peptide receptor 2 | 1.165e-4 | -2.763e+0 |
| cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 1.372e-4 | -2.764e+0 |
| tifab | TRAF-interacting protein with forkhead-associated domain, family member B | 3.106e-5 | -2.781e+0 |
| sdc4 | syndecan 4 | 4.260e-5 | -2.785e+0 |
| cd53 | CD53 antigen | 4.827e-9 | -2.790e+0 |
| clec4a2 | C-type lectin domain family 4, member a2 | 3.655e-6 | -2.790e+0 |
| p2ry10 | purinergic receptor P2Y, G-protein coupled 10 | 2.656e-5 | -2.791e+0 |
| hk3 | hexokinase 3 | 5.190e-7 | -2.795e+0 |
| p2ry13 | purinergic receptor P2Y, G-protein coupled 13 | 2.711e-4 | -2.796e+0 |
| ankrd57 | ankyrin repeat domain 57 | 1.547e-7 | -2.797e+0 |
| stab1 | stabilin 1 | 2.158e-4 | -2.801e+0 |
| ly9 | lymphocyte antigen 9 | 7.690e-8 | -2.837e+0 |
| h2-m3 | histocompatibility 2, M region locus 3 | 1.068e-7 | -2.845e+0 |
| cpa3 | carboxypeptidase A3, mast cell | 1.659e-3 | -2.856e+0 |
| ly96 | lymphocyte antigen 96 | 1.748e-6 | -2.864e+0 |
| a630077b13rik | RIKEN cDNA A630077B13 gene | 2.698e-6 | -2.868e+0 |
| mmp13 | matrix metallopeptidase 13 | 1.069e-4 | -2.868e+0 |
| cytip | cytohesin 1 interacting protein | 1.349e-6 | -2.871e+0 |
| cd33 | CD33 antigen | 1.750e-6 | -2.874e+0 |
| il13ra1 | interleukin 13 receptor, alpha 1 | 2.286e-6 | -2.883e+0 |
| ugt1a9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | 1.322e-9 | -2.895e+0 |
| olfm4 | olfactomedin 4 | 2.547e-3 | -2.903e+0 |
| map3k8 | mitogen-activated protein kinase kinase kinase 8 | 3.649e-11 | -2.906e+0 |
| ms4a7 | membrane-spanning 4-domains, subfamily A, member 7 | 2.207e-7 | -2.907e+0 |
| tmem86a | transmembrane protein 86A | 1.620e-4 | -2.910e+0 |
| gpr34 | G protein-coupled receptor 34 | 2.458e-3 | -2.911e+0 |
| osm | oncostatin M | 3.299e-5 | -2.919e+0 |
| af251705 | cDNA sequence AF251705 | 1.513e-5 | -2.920e+0 |
| centa2 | centaurin, alpha 2 | 9.282e-6 | -2.924e+0 |
| 1190002h23rik | RIKEN cDNA 1190002H23 gene | 3.600e-6 | -2.930e+0 |
| scpep1 | serine carboxypeptidase 1 | 9.313e-7 | -2.941e+0 |
| gbp2 | guanylate binding protein 2 | 6.704e-9 | -2.942e+0 |
| apobec1 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | 3.270e-6 | -2.950e+0 |
| abcc3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | 8.512e-5 | -2.968e+0 |
| 4930506m07rik | RIKEN cDNA 4930506M07 gene | 8.156e-6 | -2.972e+0 |
| nfkbiz | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 3.927e-5 | -2.988e+0 |
| smpdl3a | sphingomyelin phosphodiesterase, acid-like 3A | 5.931e-7 | -2.996e+0 |
| 4631422o05rik | RIKEN cDNA 4631422O05 gene | 1.863e-6 | -3.003e+0 |
| pira6 | paired-Ig-like receptor A6 | 3.551e-9 | -3.011e+0 |
| arsb | arylsulfatase B | 2.767e-7 | -3.011e+0 |
| timd4 | T-cell immunoglobulin and mucin domain containing 4 | 3.363e-4 | -3.013e+0 |
| gbp3 | guanylate binding protein 3 | 9.959e-12 | -3.015e+0 |
| sfxn3 | sideroflexin 3 | 1.681e-10 | -3.020e+0 |
| prdm1 | PR domain containing 1, with ZNF domain | 1.373e-11 | -3.032e+0 |
| p2rx7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 1.595e-10 | -3.033e+0 |
| itgb5 | integrin beta 5 | 9.284e-6 | -3.057e+0 |
| apoc1 | apolipoprotein C-I | 2.277e-5 | -3.059e+0 |
| dock10 | dedicator of cytokinesis 10 | 1.574e-6 | -3.062e+0 |
| phf11 | PHD finger protein 11 | 1.014e-6 | -3.074e+0 |
| nlrp3 | NLR family, pyrin domain containing 3 | 1.402e-8 | -3.079e+0 |
| socs3 | suppressor of cytokine signaling 3 | 1.313e-4 | -3.087e+0 |
| hspa1a | heat shock protein 1A | 5.057e-3 | -3.097e+0 |
| tlr2 | toll-like receptor 2 | 1.504e-7 | -3.098e+0 |
| trf | transferrin | 5.776e-6 | -3.101e+0 |
| ifi47 | interferon gamma inducible protein 47 | 1.228e-8 | -3.103e+0 |
| parp12 | poly (ADP-ribose) polymerase family, member 12 | 1.701e-8 | -3.128e+0 |
| stap1 | signal transducing adaptor family member 1 | 7.989e-6 | -3.142e+0 |
| 100042856 | predicted gene, 100042856 | 7.501e-11 | -3.149e+0 |
| irg1 | immunoresponsive gene 1 | 5.025e-5 | -3.155e+0 |
| nfil3 | nuclear factor, interleukin 3, regulated | 7.106e-8 | -3.162e+0 |
| p2ry12 | purinergic receptor P2Y, G-protein coupled 12 | 9.858e-5 | -3.188e+0 |
| rab20 | RAB20, member RAS oncogene family | 5.432e-7 | -3.219e+0 |
| mrc1 | mannose receptor, C type 1 | 2.590e-3 | -3.232e+0 |
| msr1 | macrophage scavenger receptor 1 | 3.429e-5 | -3.240e+0 |
| il1a | interleukin 1 alpha | 1.415e-6 | -3.242e+0 |
| basp1 | brain abundant, membrane attached signal protein 1 | 3.485e-14 | -3.247e+0 |
| hdc | histidine decarboxylase | 2.548e-5 | -3.258e+0 |
| cfp | complement factor properdin | 3.438e-7 | -3.268e+0 |
| csf1r | colony stimulating factor 1 receptor | 6.144e-6 | -3.279e+0 |
| hfe | hemochromatosis | 1.022e-5 | -3.281e+0 |
| olr1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 1.773e-4 | -3.282e+0 |
| pygl | liver glycogen phosphorylase | 6.551e-14 | -3.288e+0 |
| ccl24 | chemokine (C-C motif) ligand 24 | 4.093e-4 | -3.299e+0 |
| ugt1a6a | UDP glucuronosyltransferase 1 family, polypeptide A6A | 1.266e-11 | -3.319e+0 |
| lyz2 | lysozyme 2 | 7.492e-10 | -3.320e+0 |
| clec4e | C-type lectin domain family 4, member e | 4.292e-5 | -3.323e+0 |
| tlr13 | toll-like receptor 13 | 9.118e-8 | -3.330e+0 |
| fos | FBJ osteosarcoma oncogene | 1.141e-2 | -3.332e+0 |
| abca1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 1.573e-5 | -3.348e+0 |
| igsf6 | immunoglobulin superfamily, member 6 | 4.812e-8 | -3.387e+0 |
| c5ar1 | complement component 5a receptor 1 | 2.869e-5 | -3.395e+0 |
| mertk | c-mer proto-oncogene tyrosine kinase | 1.135e-5 | -3.406e+0 |
| casp4 | caspase 4, apoptosis-related cysteine peptidase | 1.210e-10 | -3.427e+0 |
| cd86 | CD86 antigen | 1.384e-7 | -3.438e+0 |
| gm885 | gene model 885, (NCBI) | 1.422e-9 | -3.453e+0 |
| ccr1 | chemokine (C-C motif) receptor 1 | 2.720e-6 | -3.460e+0 |
| ccr5 | chemokine (C-C motif) receptor 5 | 9.082e-7 | -3.466e+0 |
| ccrl2 | chemokine (C-C motif) receptor-like 2 | 2.334e-6 | -3.472e+0 |
| bhlhb2 | basic helix-loop-helix domain containing, class B2 | 4.224e-5 | -3.483e+0 |
| prg2 | proteoglycan 2, bone marrow | 2.148e-3 | -3.484e+0 |
| 4732429d16rik | RIKEN cDNA 4732429D16 gene | 7.568e-7 | -3.486e+0 |
| plau | plasminogen activator, urokinase | 5.810e-6 | -3.489e+0 |
| oasl2 | 2'-5' oligoadenylate synthetase-like 2 | 1.384e-9 | -3.519e+0 |
| ctsb | cathepsin B | 5.729e-7 | -3.526e+0 |
| pla2g7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 1.348e-7 | -3.545e+0 |
| dab2 | disabled homolog 2 (Drosophila) | 7.873e-5 | -3.557e+0 |
| hmox1 | heme oxygenase (decycling) 1 | 5.139e-6 | -3.579e+0 |
| gatm | glycine amidinotransferase (L-arginine:glycine amidinotransferase) | 4.096e-9 | -3.657e+0 |
| ifi27 | interferon, alpha-inducible protein 27 | 3.210e-7 | -3.659e+0 |
| cfh | complement component factor h | 9.521e-5 | -3.679e+0 |
| niban | niban protein | 3.956e-11 | -3.702e+0 |
| slc40a1 | solute carrier family 40 (iron-regulated transporter), member 1 | 2.133e-4 | -3.715e+0 |
| fyb | FYN binding protein | 2.884e-9 | -3.726e+0 |
| pyhin1 | pyrin and HIN domain family, member 1 | 8.938e-9 | -3.735e+0 |
| gpr160 | G protein-coupled receptor 160 | 1.099e-8 | -3.741e+0 |
| cd36 | CD36 antigen | 3.428e-8 | -3.769e+0 |
| glipr1 | GLI pathogenesis-related 1 (glioma) | 5.532e-11 | -3.796e+0 |
| nr4a1 | nuclear receptor subfamily 4, group A, member 1 | 2.310e-5 | -3.799e+0 |
| il6 | interleukin 6 | 2.963e-5 | -3.807e+0 |
| selplg | selectin, platelet (p-selectin) ligand | 2.680e-14 | -3.812e+0 |
| atf3 | activating transcription factor 3 | 7.341e-8 | -3.847e+0 |
| abcg3 | ATP-binding cassette, sub-family G (WHITE), member 3 | 6.711e-7 | -3.852e+0 |
| rgs1 | regulator of G-protein signaling 1 | 3.164e-5 | -3.865e+0 |
| cxcl3 | chemokine (C-X-C motif) ligand 3 | 6.650e-5 | -3.868e+0 |
| stfa1 | stefin A1 | 1.165e-4 | -3.870e+0 |
| fcgr1 | Fc receptor, IgG, high affinity I | 1.436e-6 | -3.872e+0 |
| clec7a | C-type lectin domain family 7, member a | 7.969e-7 | -3.897e+0 |
| slfn2 | schlafen 2 | 1.613e-8 | -3.904e+0 |
| fcgr4 | Fc receptor, IgG, low affinity IV | 2.834e-6 | -3.906e+0 |
| ai662270 | expressed sequence AI662270 | 1.264e-7 | -3.933e+0 |
| ab124611 | cDNA sequence AB124611 | 4.053e-7 | -3.959e+0 |
| bank1 | B-cell scaffold protein with ankyrin repeats 1 | 9.211e-10 | -3.973e+0 |
| ms4a4c | membrane-spanning 4-domains, subfamily A, member 4C | 3.816e-7 | -3.977e+0 |
| gpr65 | G-protein coupled receptor 65 | 6.041e-9 | -3.979e+0 |
| spp1 | secreted phosphoprotein 1 | 1.298e-5 | -3.996e+0 |
| bcl2a1a | B-cell leukemia/lymphoma 2 related protein A1a | 7.795e-7 | -4.014e+0 |
| clec4n | C-type lectin domain family 4, member n | 2.746e-6 | -4.026e+0 |
| cxcl1 | chemokine (C-X-C motif) ligand 1 | 1.337e-5 | -4.033e+0 |
| ccl4 | chemokine (C-C motif) ligand 4 | 1.220e-6 | -4.039e+0 |
| cd5l | CD5 antigen-like | 1.312e-4 | -4.049e+0 |
| lpxn | leupaxin | 1.129e-11 | -4.070e+0 |
| gm2a | GM2 ganglioside activator protein | 7.560e-15 | -4.080e+0 |
| hck | hemopoietic cell kinase | 8.524e-8 | -4.091e+0 |
| adrb2 | adrenergic receptor, beta 2 | 9.883e-9 | -4.096e+0 |
| casp1 | caspase 1 | 3.630e-7 | -4.096e+0 |
| il18 | interleukin 18 | 1.733e-7 | -4.102e+0 |
| tlr1 | toll-like receptor 1 | 2.061e-6 | -4.166e+0 |
| pld4 | phospholipase D family, member 4 | 1.196e-10 | -4.190e+0 |
| cd68 | CD68 antigen | 7.615e-8 | -4.195e+0 |
| fcna | ficolin A | 6.441e-5 | -4.207e+0 |
| ccl7 | chemokine (C-C motif) ligand 7 | 1.045e-6 | -4.246e+0 |
| cxcl10 | chemokine (C-X-C motif) ligand 10 | 3.745e-9 | -4.253e+0 |
| loc100044979 | similar to Gpr137b protein | 3.386e-13 | -4.260e+0 |
| slc15a3 | solute carrier family 15, member 3 | 1.832e-9 | -4.286e+0 |
| fcrls | Fc receptor-like S, scavenger receptor | 1.067e-4 | -4.299e+0 |
| stfa3 | stefin A3 | 1.529e-4 | -4.330e+0 |
| ear3 | eosinophil-associated, ribonuclease A family, member 3 | 7.671e-6 | -4.466e+0 |
| eg622976 | predicted gene, EG622976 | 3.838e-8 | -4.485e+0 |
| lgmn | legumain | 9.034e-7 | -4.503e+0 |
| p2ry6 | pyrimidinergic receptor P2Y, G-protein coupled, 6 | 7.557e-6 | -4.526e+0 |
| lilrb4 | leukocyte immunoglobulin-like receptor, subfamily B, member 4 | 8.679e-12 | -4.539e+0 |
| ccl2 | chemokine (C-C motif) ligand 2 | 2.929e-8 | -4.580e+0 |
| rnase4 | ribonuclease, RNase A family 4 | 4.941e-7 | -4.580e+0 |
| cd14 | CD14 antigen | 6.273e-8 | -4.615e+0 |
| ifi204 | interferon activated gene 204 | 1.807e-7 | -4.617e+0 |
| cybb | cytochrome b-245, beta polypeptide | 8.253e-11 | -4.744e+0 |
| 1810015c04rik | RIKEN cDNA 1810015C04 gene | 2.400e-16 | -4.797e+0 |
| c3ar1 | complement component 3a receptor 1 | 2.436e-6 | -4.862e+0 |
| tgfbi | transforming growth factor, beta induced | 1.916e-11 | -4.978e+0 |
| clec4a3 | C-type lectin domain family 4, member a3 | 1.435e-7 | -5.086e+0 |
| ctsh | cathepsin H | 4.330e-7 | -5.102e+0 |
| emr1 | EGF-like module containing, mucin-like, hormone receptor-like sequence 1 | 3.521e-7 | -5.147e+0 |
| ottmusg00000000971 | predicted gene, OTTMUSG00000000971 | 1.267e-11 | -5.159e+0 |
| lgals3 | lectin, galactose binding, soluble 3 | 2.864e-9 | -5.177e+0 |
| ccl12 | chemokine (C-C motif) ligand 12 | 3.156e-6 | -5.240e+0 |
| cd48 | CD48 antigen | 1.395e-12 | -5.290e+0 |
| c1qc | complement component 1, q subcomponent, C chain | 8.218e-6 | -5.297e+0 |
| ms4a6c | membrane-spanning 4-domains, subfamily A, member 6C | 4.850e-9 | -5.310e+0 |
| slc11a1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 5.141e-8 | -5.347e+0 |
| il1b | interleukin 1 beta | 3.067e-9 | -5.431e+0 |
| ms4a6b | membrane-spanning 4-domains, subfamily A, member 6B | 1.555e-8 | -5.570e+0 |
| c1qa | complement component 1, q subcomponent, alpha polypeptide | 2.019e-6 | -5.609e+0 |
| ifi205 | interferon activated gene 205 | 2.331e-14 | -5.700e+0 |
| ai607873 | expressed sequence AI607873 | 1.171e-9 | -5.801e+0 |
| cxcr4 | chemokine (C-X-C motif) receptor 4 | 7.085e-13 | -5.819e+0 |
| c1qb | complement component 1, q subcomponent, beta polypeptide | 8.382e-7 | -5.873e+0 |
| ear2 | eosinophil-associated, ribonuclease A family, member 2 | 1.931e-7 | -6.016e+0 |
| s100a8 | S100 calcium binding protein A8 (calgranulin A) | 4.413e-9 | -6.115e+0 |
| mpeg1 | macrophage expressed gene 1 | 3.805e-11 | -6.235e+0 |
| ly86 | lymphocyte antigen 86 | 1.636e-9 | -6.301e+0 |
| aif1 | allograft inflammatory factor 1 | 3.331e-8 | -6.343e+0 |
| s100a9 | S100 calcium binding protein A9 (calgranulin B) | 5.248e-10 | -6.368e+0 |
| cxcl2 | chemokine (C-X-C motif) ligand 2 | 1.509e-8 | -6.474e+0 |
| cd83 | CD83 antigen | 2.270e-13 | -6.705e+0 |
| ctss | cathepsin S | 5.033e-14 | -7.630e+0 |